Melqart Asset Management (Uk) LTD Bridge Bio Pharma, Inc. Transaction History
Melqart Asset Management (Uk) LTD
- $1.03 Billion
- Q3 2024
A detailed history of Melqart Asset Management (Uk) LTD transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Melqart Asset Management (Uk) LTD holds 403,485 shares of BBIO stock, worth $15 Million. This represents 1.0% of its overall portfolio holdings.
Number of Shares
403,485
Previous 307,911
31.04%
Holding current value
$15 Million
Previous $7.8 Million
31.71%
% of portfolio
1.0%
Previous 0.66%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
295Shares Held
170MCall Options Held
10.4MPut Options Held
2.36M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$937 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$932 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$527 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$462 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$225 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.5B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...